Insider Selling: Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells 2,000 Shares of Stock

Nu Skin Enterprises, Inc. (NYSE:NUSGet Free Report) Director Andrew D. Lipman sold 2,000 shares of the stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $18.55, for a total value of $37,100.00. Following the sale, the director now owns 31,225 shares in the company, valued at approximately $579,223.75. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Nu Skin Enterprises Stock Up 3.7 %

NYSE:NUS traded up $0.68 during mid-day trading on Thursday, hitting $18.97. The company had a trading volume of 479,687 shares, compared to its average volume of 571,946. The business has a fifty day simple moving average of $18.29 and a 200-day simple moving average of $21.42. The company has a current ratio of 1.62, a quick ratio of 0.94 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises, Inc. has a 1 year low of $16.15 and a 1 year high of $45.55. The firm has a market capitalization of $937.31 million, a price-to-earnings ratio of 15.50 and a beta of 1.17.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last released its quarterly earnings data on Wednesday, November 1st. The company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.64 by ($0.08). Nu Skin Enterprises had a net margin of 2.92% and a return on equity of 13.44%. The company had revenue of $498.80 million during the quarter, compared to analysts’ expectations of $520.09 million. During the same period last year, the business earned $0.47 earnings per share. The company’s revenue for the quarter was down 7.3% compared to the same quarter last year. Equities analysts forecast that Nu Skin Enterprises, Inc. will post 1.76 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 6th. Stockholders of record on Friday, November 24th were paid a dividend of $0.39 per share. The ex-dividend date of this dividend was Wednesday, November 22nd. This represents a $1.56 annualized dividend and a dividend yield of 8.22%. Nu Skin Enterprises’s dividend payout ratio is presently 132.20%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Citigroup reduced their price target on Nu Skin Enterprises from $30.00 to $23.00 and set a “neutral” rating on the stock in a research note on Friday, September 29th. Stifel Nicolaus reduced their price target on Nu Skin Enterprises from $35.00 to $27.00 and set a “hold” rating on the stock in a research note on Monday, October 16th. DA Davidson reduced their price target on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 5th. TheStreet lowered Nu Skin Enterprises from a “c” rating to a “d+” rating in a research report on Wednesday, November 1st. Finally, StockNews.com initiated coverage on Nu Skin Enterprises in a research report on Thursday, October 5th. They issued a “hold” rating on the stock. Five analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $27.50.

Get Our Latest Stock Analysis on Nu Skin Enterprises

Institutional Trading of Nu Skin Enterprises

Large investors have recently modified their holdings of the business. Trilogy Capital Inc. grew its stake in shares of Nu Skin Enterprises by 22.9% during the second quarter. Trilogy Capital Inc. now owns 9,322 shares of the company’s stock valued at $267,000 after acquiring an additional 1,740 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Nu Skin Enterprises during the second quarter valued at about $21,804,000. Counterpoint Mutual Funds LLC acquired a new stake in shares of Nu Skin Enterprises during the third quarter valued at about $124,000. Aristotle Capital Boston LLC grew its stake in shares of Nu Skin Enterprises by 2.3% during the second quarter. Aristotle Capital Boston LLC now owns 783,544 shares of the company’s stock valued at $26,014,000 after acquiring an additional 17,402 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its stake in shares of Nu Skin Enterprises by 20.9% during the second quarter. Russell Investments Group Ltd. now owns 55,182 shares of the company’s stock valued at $1,832,000 after acquiring an additional 9,555 shares in the last quarter. 73.62% of the stock is currently owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.

Recommended Stories

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.